Join EVERSANA at BIO-EUROPE SPRING, 4-6 November 2024 in Stockholm, Sweden. With over 40 clients and a growing number of engagements in Europe, EVERSANA is leading the way as the only end-to-end provider of #commercialisation services that span all stages of the product life cycle to deliver long-term value for patients, physicians and payers. Schedule a meeting today to meet with our team in Barcelona: https://ow.ly/wlYy50TEx6w. #BIOEurope
About us
EVERSANA® is a leading independent provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 650 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit eversana.com.
- Website
-
http://eversana.com
External link for EVERSANA
- Industry
- Pharmaceutical Manufacturing
- Company size
- 5,001-10,000 employees
- Headquarters
- Chicago, IL
- Type
- Privately Held
- Specialties
- Regulatory, Management & Specialty Consulting, Research & Insights, Global Pricing Strategies, Patient, Payer & Provider Marketing Services, Field Medical, Market Access & Sales , Global Channel Management & 3PL, Specialty Pharmacy & In-Home Nursing, HUB & Adherence Solutions, Affordability Programs, Medical Communications & Pharmacovigilance, Revenue Management, Digital Strategies & Therapy Transformation, Patient Analytics Services, Integrated Patient-Level Data, Commercial Analytics Platform, RWE & HEOR Global Services, Global Launch Expertise, and Payer Reimbursement Strategies
Locations
Employees at EVERSANA
Updates
-
With the conclusion of Frontiers Health, we’re taking a moment to reflect on our role as Presenting Sponsor. Each session highlighted the inspiring efforts of this global community towards a healthier world for all. A big thank you to the organizers, speakers and health innovators for being with us in Berlin. Let’s continue to push beyond today's possibilities. Until next year! #FH24 #HealthInnovation #LifeSciences#HealthEquity
-
Read the full case study: https://ow.ly/eEsa50TzmtH Navigating the complexities of rare diseases requires innovative solutions. Discover how a gene therapy client partnered with EVERSANA to leverage Real-World Data (RWD) and redefine the patient journey, ultimately supporting the commercialization of their therapy. Why is this important? • Comprehensive Insights: Gain a deep, data-driven understanding of patient journeys, prescribing patterns, and geographical factors. • Targeted Care: Identify high-value patient and healthcare provider (HCP) targets with precision. • Strategic Decision-Making: Utilize robust data to inform clinical and go-to-market strategies. Dive into the full case study to see how data-driven strategies can revolutionize your approach to rare disease therapy. #MarketAccess #DataAnalytics #Healthcare #Pharma #GeneTherapy #PatientJourney #RWD #EVERSANA #PredictiveModeling #RareDiseases
-
Good morning from Frontiers Health 2024! Day 2 is underway, and we’re excited to dive deeper into the latest in life sciences and celebrate the innovators and solutions creating a healthier world for all. #FH24 #HealthInnovation #Berlin Roberto Ascione
-
From start to finish, today was all about incredible insights and groundbreaking discussions at Frontiers Health Here’s a look back at the key moments. Can’t wait for day 2! #FH24 #HealthInnovation
-
Unlock patient access by utilizing the right tools for success! Discover how EVERSANA’s ACTICS eAccess seamless integration of people, data and technology helps transform patient journeys and allows Field Reimbursement Managers (FRMs) to break down barriers and accelerate time to therapy. Learn more: https://ow.ly/H3Wf50TMFZw
-
What a morning in Berlin! Here’s some highlights of the thought-provoking sessions so far at Frontiers Health. #FH24 #HealthInnovation Roberto Ascione Kristin Milburn Mike Ryan
-
Read the Full Case Study: https://ow.ly/umEe50TtKH7 At EVERSANA, we’re pioneering the way forward in telehealth by understanding the drivers and barriers to its adoption. Our latest case study with a top 10 pharmaceutical company showcases how we use AI/ML to identify patients and providers most likely to use telehealth services. Key Highlights: • In-Depth Telehealth Analysis: Assessing historical telehealth use and identifying key factors driving adoption. • Patient and Provider Segmentation: Creating detailed personas based on telehealth proactivity and accessibility. • High-Value HCP Identification: Pinpointing 2,000 high-value healthcare providers responsible for treating 40% of high-value patients. Discover how our innovative approach is transforming telehealth adoption and setting new standards in healthcare delivery. Click below to read the full case study and see how EVERSANA is leading the way in healthcare innovation. #HealthcareInnovation #PredictiveModeling #MachineLearning #Telehealth #PatientCare #EVERSANA
-
We’re live at Frontiers Health 2024! Jim Lang and Roberto Ascione have just kicked off the day with inspiring opening remarks, setting the stage for an exploration of where the known meets the unknown in health innovation. #FH24 #Berlin #HealthInnovation
-
Explore the delicate balance between technophobia and rapid technological advancement, where the fear of being left behind is real, during Vivek Ahuja’s presentation, “To AI or Not to AI,” at WDSC Americas. The session will also highlight a case study that explores this common experience shared by many manufacturers today. Learn more or schedule a meeting with our drug safety experts: https://ow.ly/SRlu50THexH